Meitav Investment House’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,700
Closed -$661K 495
2019
Q3
$661K Hold
6,700
0.05% 204
2019
Q2
$614K Sell
6,700
-1,000
-13% -$95K 0.04% 215
2019
Q1
$706K Buy
7,700
+3,400
+79% +$297K 0.04% 201
2018
Q4
$273K Sell
4,300
-100
-2% -$7.38K 0.02% 275
2018
Q3
$393K Sell
4,400
-200
-4% -$17.7K 0.02% 362
2018
Q2
$1.08M Buy
+4,600
New +$382K 0.05% 191

Other funds holding CELG

Meitav Investment House's CELG Position: Q4 2019 in Review

Meitav Investment House sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,700 shares — an estimated $661K sold.

Meitav Investment House first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $1.08M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Meitav Investment House reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Meitav Investment House sold 6,700 Celgene Corp shares in Q4 2019, an estimated $661K.
  • Meitav Investment House first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
  • Meitav Investment House's Celgene Corp position peaked at $1.08M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Meitav Investment House's 13F filing for Q4 2019, filed 10 Feb 2020.